|
UNITED STATES |
|||
|
SECURITIES AND EXCHANGE COMMISSION |
|||
|
Washington, D.C. 20549 |
|||
|
|
|||
|
|
|||
|
FORM 8-K |
|||
|
|
|||
|
|
|||
|
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|||
|
|
|||
|
|
|||
|
Date of Report (Date of the earliest event reported) October 2, 2017 |
|||
|
|
|||
|
|
|||
|
|
|||
|
ULTRALIFE CORPORATION |
|||
|
(Exact name of registrant as specified in its charter) |
|||
|
|
|||
|
|
|||
|
|
|||
|
Delaware |
000-20852 |
16-1387013 |
|
|
(State of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
|||
|
2000 Technology Parkway, Newark, New York |
14513 |
||
|
(Address of principal executive offices) |
(Zip Code) |
||
|
|
|||
|
(315) 332-7100 |
|||
|
(Registrant’s telephone number, including area code) |
|||
|
|
|||
|
|
|||
|
|
|||
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
|||
|
|
|||
|
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|||
|
|
|||
|
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|||
|
|
|||
|
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|||
|
|
|||
|
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ] |
|||
Item 8.01 Other Events
In a press release dated October 2, 2017, Ultralife Corporation (NASDAQ: ULBI) announced that it has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $49.8 million from the U.S. Government’s Defense Logistic Agency (DLA) for its hybrid lithium manganese dioxide/carbon monofluoride (CFx) non-rechargeable BA-5790 and BA-5795 batteries. The award is for five years with the amounts and timing of deliveries at the discretion of the DLA. Initial deliveries under this contract are expected to begin by the first quarter of 2019.
Item 9.01 Financial Statements, Pro Forma Financials and Exhibits
(d) Exhibits
|
Exhibit |
||
|
Number |
Description |
|
| 99.1 |
Press Release of Ultralife Corporation dated October 2, 2017 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ULTRALIFE CORPORATION |
|
|
|
|
|
|
October 2, 2017 |
By: |
/s/ Philip A. Fain |
|
|
|
Chief Financial Officer and Treasurer |
Exhibit 99.1
|
Company Contact: |
Investor Relations Contact: |
|
Ultralife Corporation |
LHA |
|
Philip A. Fain |
Jody Burfening |
|
(315) 332-7100 |
(212) 838-3777 |
|
pfain@ulbi.com |
jburfening@lhai.com |
Ultralife Corporation Receives $49.8 Million IDIQ Award
from Defense Logistics Agency for Its New CFx Military Batteries
NEWARK, N.Y. October 2, 2017 -- Ultralife Corporation (NASDAQ: ULBI) has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $49.8 million from the U.S. Government’s Defense Logistic Agency (DLA) for its hybrid lithium manganese dioxide/carbon monofluoride (CFx) non-rechargeable BA-5790 and BA-5795 batteries. The award is for five years with the amounts and timing of deliveries at the discretion of the DLA. Initial deliveries under this contract are expected to begin by the first quarter of 2019.
“Ultralife is a long-standing supplier to the U.S. military focused on the continued development of new products to meet the ongoing needs of the warfighter. Building on the success of our existing lithium manganese dioxide family of primary batteries, our new CFx batteries deliver 1.5 times the energy in the same size and weight as our legacy batteries making them ideal for longer duration missions, while maintaining our proven safety, performance and reliability under the toughest of conditions,” said Michael D. Popielec, President and Chief Executive Officer.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.